Table 1.
Treatment | Ejection Fraction Effects | Effects |
---|---|---|
Anakinra | CPX parameters and HF events | Peak aerobic capacity (VO2) and ventilatory efficiency (VE/VCO2 slope). |
Adverse events | Clinical, cardiac, and non-cardiac deaths, hospitalization, and injection-site reactions. | |
QoL measures | General improvement in quality of life | |
Biomarkers | High-sensitive C-reactive protein and NT-proBNP levels |